[1] |
Navallas M, Inarejos Clemente EJ, Iglesias E, et al. Autoinflammatory diseases in childhood, part 1: Monogenic syndromes[J]. Pediatr Radiol, 2020, 50(3):415-430.
doi: 10.1007/s00247-019-04536-9
pmid: 32065272
|
[2] |
Gaal A, Basiaga ML, Zhao YD, et al. Pediatric chronic nonbacterial osteomyelitis of the mandible: Seattle Children's hospital 22-patient experience[J]. Pediatr Rheumatol Online J, 2020, 18(1):4.
doi: 10.1186/s12969-019-0384-8
pmid: 31941491
|
[3] |
何启艇, 邱波, 吴小松. 慢性复发性多灶性骨髓炎的诊断和治疗进展[J]. 实用骨科杂志, 2019, 25(9):819-821.
|
[4] |
Padwa BL, Dentino K, Robson CD, et al. Pediatric chronic nonbacterial osteomyelitis of the jaw: Clinical, radiographic, and histopathologic features[J]. J Oral Maxillofac Surg, 2016, 74(12):2393-2402.
doi: 10.1016/j.joms.2016.05.021
|
[5] |
Golla A, Jansson A, Ramser J, et al. Chronic recurrent multifocal osteomyelitis (CRMO):Evidence for a susceptibility gene located on chromosome 18q21.3-18q22[J]. Eur J Hum Genet, 2002, 10(3):217-221.
doi: 10.1038/sj.ejhg.5200789
|
[6] |
Hofmann SR, Kapplusch F, Girschick HJ, et al. Chronic recurrent multifocal osteomyelitis (CRMO):Presentation, pathogenesis, and treatment[J]. Curr Osteoporos Rep, 2017, 15(6):542-554.
doi: 10.1007/s11914-017-0405-9
pmid: 29080202
|
[7] |
Abe K, Fuchs H, Lisse T, et al. New ENU-induced semidominant mutation, Ali18, causes inflammatory arthritis, dermatitis, and osteoporosis in the mouse[J]. Mamm Genome, 2006, 17(9):915-926.
pmid: 16964445
|
[8] |
Abe K, Cox A, Takamatsu N, et al. Gain-of-function mutations in a member of the Src family kinases cause autoinflammatory bone disease in mice and humans[J]. Proc Natl Acad Sci USA, 2019, 116(24):11872-11877.
doi: 10.1073/pnas.1819825116
pmid: 31138708
|
[9] |
Chitu V, Ferguson PJ, de Bruijn R, et al. Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice[J]. Blood, 2009, 114(12):2497-2505.
doi: 10.1182/blood-2009-02-204925
pmid: 19608749
|
[10] |
Gurung P, Burton A, Kanneganti TD. NLRP3 inflammasome plays a redundant role with caspase 8 to promote IL-1β-mediated osteomyelitis[J]. Proc Natl Acad Sci USA, 2016, 113(16):4452-4457.
doi: 10.1073/pnas.1601636113
pmid: 27071119
|
[11] |
Koryllou A, Mejbri M, Theodoropoulou K, et al. Chronic nonbacterial osteomyelitis in children[J]. Children (Basel), 2021, 8(7):551.
|
[12] |
Cox AJ, Ferguson PJ. Update on the genetics of nonbacterial osteomyelitis in humans[J]. Curr Opin Rheumatol, 2018, 30(5):521-525.
doi: 10.1097/BOR.0000000000000530
pmid: 29912021
|
[13] |
Zhao DY, McCann L, Hahn G, et al. Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO)[J]. J Transl Autoimmun, 2021, 4: 100095.
doi: 10.1016/j.jtauto.2021.100095
|
[14] |
张祥洪, 朱娜, 彭伟秋, 等. 慢性复发性多病灶性骨髓炎的研究进展[J]. 实用骨科杂志, 2019, 25(4):343-347.
|
[15] |
Berthelot JM, de la Cochetière MF, Potel G, et al. Evidence supporting a role for dormant bacteria in the pathogenesis of spondylarthritis[J]. Joint Bone Spine, 2013, 80(2):135-140.
doi: 10.1016/j.jbspin.2012.08.002
|
[16] |
Zeus M, Janssen S, Laws HJ, et al. Results from a pilot study on the oral microbiome in children and adolescents with chronic nonbacterial osteomyelitis[J]. Z Rheumatol, 2021: 2021Jul1.
|
[17] |
Theofilopoulos AN, Gonzalez-Quintial R, Lawson BR, et al. Sensors of the innate immune system: Their link to rheumatic diseases[J]. Nat Rev Rheumatol, 2010, 6(3):146-156.
doi: 10.1038/nrrheum.2009.278
pmid: 20142813
|
[18] |
Vandenhaute J, Wouters CH, Matthys P. Natural killer cells in systemic autoinflammatory diseases: A focus on systemic juvenile idiopathic arthritis and macrophage activation syndrome[J]. Front Immunol, 2020, 10: 3089.
doi: 10.3389/fimmu.2019.03089
|
[19] |
Hofmann SR, Morbach H, Schwarz T, et al. Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression[J]. Clin Immunol, 2012, 145(1):69-76.
doi: 10.1016/j.clim.2012.07.012
pmid: 22940633
|
[20] |
Hofmann SR, Kubasch AS, Ioannidis C, et al. Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1β expression and release[J]. Clin Immunol, 2015, 161(2):300-307.
doi: 10.1016/j.clim.2015.09.013
pmid: 26404542
|
[21] |
Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems[J]. J Clin Immunol, 2009, 29(5):555-567.
doi: 10.1007/s10875-009-9316-6
pmid: 19585227
|
[22] |
Hofmann SR, Kapplusch F, Mäbert K, et al. The molecular pathophysiology of chronic non-bacterial osteomyelitis (CNO)-a systematic review[J]. Mol Cell Pediatr, 2017, 4(1):7.
doi: 10.1186/s40348-017-0073-y
pmid: 28685269
|
[23] |
Zhao YD, Ferguson PJ. Chronic non-bacterial osteomyelitis and autoinflammatory bone diseases[J]. Clin Immunol, 2020, 216: 108458.
doi: 10.1016/j.clim.2020.108458
|
[24] |
Navallas M, Inarejos Clemente EJ, Iglesias E, et al. Autoinflammatory diseases in childhood, part 2: Polygenic syndromes[J]. Pediatr Radiol, 2020, 50(3):431-444.
doi: 10.1007/s00247-019-04544-9
pmid: 32065273
|
[25] |
Zhao YD, Ferguson PJ. Chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis in children[J]. Pediatr Clin North Am, 2018, 65(4):783-800.
doi: 10.1016/j.pcl.2018.04.003
|
[26] |
Khanna G, Sato TSP, Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis[J]. Radiographics, 2009, 29(4):1159-1177.
doi: 10.1148/rg.294085244
pmid: 19605663
|
[27] |
Jansson A, Renner ED, Ramser J, et al. Classification of non-bacterial osteitis: Retrospective study of clinical, immunological and genetic aspects in 89 patients[J]. Rheumatology (Oxford), 2007, 46(1):154-160.
doi: 10.1093/rheumatology/kel190
|
[28] |
Wipff J, Costantino F, Lemelle I, et al. A large national cohort of French patients with chronic recurrent multifocal osteitis[J]. Arthritis Rheumatol, 2015, 67(4):1128-1137.
doi: 10.1002/art.v67.4
|
[29] |
Job-Deslandre C, Krebs S, Kahan A. Chronic recurrent multifocal osteomyelitis: Five-year outcomes in 14 pediatric cases[J]. Jo Bone Spine, 2001, 68(3):245-251.
|
[30] |
Costa-Reis P, Sullivan KE. Chronic recurrent multifocal osteomyelitis[J]. J Clin Immunol, 2013, 33(6):1043-1056.
doi: 10.1007/s10875-013-9902-5
pmid: 23695372
|
[31] |
胡巍然, 余斌. 慢性复发性多病灶性骨髓炎的诊疗进展[J]. 骨科临床与研究杂志, 2017, 2(3):189-192.
|
[32] |
Taddio A, Ferrara G, Insalaco A, et al. Dealing with Chronic Non-Bacterial Osteomyelitis: A practical approach[J]. Pediatr Rheumatol Online J, 2017, 15(1):87.
doi: 10.1186/s12969-017-0216-7
pmid: 29287595
|
[33] |
Dailey TA, Berven MD, Vroman PJ. 99mTc-HMPAO-labeled WBC scan for the diagnosis of chronic recurrent multifocal osteomyelitis[J]. J Nucl Med Technol, 2014, 42(4):299-301.
doi: 10.2967/jnmt.114.138073
pmid: 25168250
|
[34] |
Bj0rkstén B, Boquist L. Histopathological aspects of chronic recurrent multifocal osteomyelitis[J]. J Bone Joint Surg Br, 1980, 62(3):376-380.
doi: 10.2106/00004623-198062030-00007
|
[35] |
张亚敏, 史晓虎, 李忱, 等. 慢性复发性多灶性骨髓炎研究进展[J]. 医学研究杂志, 2016, 45(7):173-175.
|
[36] |
Borzutzky A, Stern S, Reiff A, et al. Pediatric chronic nonbacterial osteomyelitis[J]. Pediatrics, 2012, 130(5):e1190-e1197.
doi: 10.1542/peds.2011-3788
|
[37] |
Georgaki M, Delli K, Paschalidi P, et al. Chronic osteomyelitis with proliferative periostitis of the mandible in a child: Report of a case managed by immunosuppressive treatment[J]. Pediatr Infect Dis J, 2022, 41(1):e10-e15.
doi: 10.1097/INF.0000000000003368
|
[38] |
Sułko J, Ebisz M, Bień S, et al. Treatment of chronic recurrent multifocal osteomyelitis with bisphosphonates in children[J]. Joint Bone Spine, 2019, 86(6):783-788.
doi: S1297-319X(19)30097-1
pmid: 31216487
|
[39] |
Papapoulos SE, Cremers SCLM. Prolonged bisphosphonate release after treatment in children[J]. N Engl J Med, 2007, 356(10):1075-1076.
|
[40] |
Juszczak B, Sułko J. Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children[J]. Rheumatol Int, 2022, 42(4):699-706.
doi: 10.1007/s00296-021-04886-4
|
[41] |
罗号, 刘忠龙, 李晓光, 等. 双膦酸盐相关性颌骨坏死发病机制的研究进展[J]. 口腔医学, 2021, 41(4):373-376.
|
[42] |
Zhao YD, Chauvin NA, Jaramillo D, et al. Aggressive therapy reduces disease activity without skeletal damage progression in chronic nonbacterial osteomyelitis[J]. J Rheumatol, 2015, 42(7):1245-1251.
doi: 10.3899/jrheum.141138
pmid: 25979712
|
[43] |
Maniscalco V, Abu-Rumeileh S, Mastrolia MV, et al. The off-label use of anakinra in pediatric systemic autoinflammatory diseases[J]. Ther Adv Musculoskelet Dis, 2020, 12: 1759720X20959575.
|
[44] |
Pardeo M, Pires Marafon D, Messia V, et al. Anakinra in a cohort of children with chronic nonbacterial osteomyelitis[J]. J Rheumatol, 2017, 44(8):1231-1238.
doi: 10.3899/jrheum.160690
pmid: 28620059
|
[45] |
Lukens JR, Gurung P, Vogel P, et al. Dietary modulation of the microbiome affects autoinflammatory disease[J]. Nature, 2014, 516(7530):246-249.
doi: 10.1038/nature13788
|
[46] |
Phillips FC, Gurung P, Kanneganti TD. Microbiota and caspase-1/caspase-8 regulate IL-1β-mediated bone disease[J]. Gut Microbes, 2016, 7(4):334-341.
pmid: 27148834
|